Krege, John H. et al "Safety Findings from the Phase 3 Studies (SAMURAI, SPARTAN) of Lasmiditan for Acute Treatment of Migraine (P1.10-009)." Neurology 92.15 Supplement (2019): P1.10-009. Web. 18 May. 2021.